Full name
SUPREMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,2 | 0,5 | 0,2 | -57 |
Gross profit (loss) | 1,7 | 2,1 | 3,4 | 64,7 |
EBITDA | 0,1 | 0,4 | 0,1 | -81,6 |
Short time liabilities | 10,6 | 10,5 | 12,9 | 22,4 |
Other operating costs | 0,1 | 0,1 | 0,1 | 78,5 |
Equity capital | 9,1 | 9,4 | 10,7 | 14,7 |
Operating profit (EBIT) | 0,1 | 0,4 | 0,1 | -84,9 |
Assets | 19,7 | 20 | 23,7 | 18,7 |
Net profit (loss) | 1,7 | 2 | 3,3 | 70,2 |
Cash | 0 | 0 | 0 | -13,1 |
Liabilities and provisions for liabilities | 10,7 | 10,6 | 13 | 22,3 |
Net income from sale | 11,1 | 13,9 | 15 | 7,8 |
Working assets | 1,8 | 2,1 | 3,9 | 87 |
Other income costs | 0 | 0 | 0 | -52,1 |
Depreciation | 0 | 0 | 0 | -11,4 |
% | % | % | p.p. | |
Profitability of capital | 18,4 | 20,9 | 31,1 | 10,2 |
Equity capital to total assets | 45,9 | 46,8 | 45,2 | -1,6 |
Gross profit margin | 15,2 | 14,9 | 22,7 | 7,8 |
EBITDA Margin | 0,8 | 3 | 0,5 | -2,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 347 | 275 | 312 | 37 |
Current financial liquidity indicator | 0.1700887680053711 | 0.19627247750759125 | 0.29990971088409424 | 0,1 |
Net dept to EBITDA | -0.2191433161497116 | -0.06710083037614822 | -0.3160971701145172 | -0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane